{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:02:53Z","timestamp":1790798573631,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.bmcl.2021.127877","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T05:17:50Z","timestamp":1614316670000},"page":"127877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Synthesis and biological evaluation of novel 4,7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors"],"prefix":"10.1016","volume":"39","author":[{"given":"K. Muni","family":"Chandra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerella Sridhar","family":"Goud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0158-5683","authenticated-orcid":false,"given":"Mohammed","family":"Arifuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3770-4725","authenticated-orcid":false,"given":"Mallika","family":"Alvala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Alvala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2021.127877_b0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"Cancer J Clin"},{"key":"10.1016\/j.bmcl.2021.127877_b0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.bmcl.2021.127877_b0015","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2021.127877_b0020","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4155\/fmc.15.71","article-title":"Carbonic anhydrase IX inhibitors in cancer therapy: an update","volume":"7","author":"Supuran","year":"2015","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmcl.2021.127877_b0025","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.bmc.2012.02.014","article-title":"Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII","volume":"20","author":"Carta","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2021.127877_b0030","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1016\/j.bmcl.2010.10.094","article-title":"7,8-Disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar\/subnanomolar range","volume":"20","author":"Maresca","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2021.127877_b0035","doi-asserted-by":"crossref","DOI":"10.2174\/1389557520666200510000718","article-title":"Recent developments of target based coumarin derivatives as potential anticancer agents","volume":"20","author":"Goud","year":"2020","journal-title":"Mini-Rev Med Chem"},{"key":"10.1016\/j.bmcl.2021.127877_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104272","article-title":"Synthesis and biological evaluation of some coumarin hybrids as selective carbonic anhydrase IX and XII inhibitors","volume":"104","author":"Thacker","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2021.127877_b0045","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bioorg.2019.04.004","article-title":"Synthesis and biological evaluation of coumarin-1,3,4-oxadiazole hybrids as selective carbonic anhydrase IX and XII inhibitors","volume":"87","author":"Narella","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2021.127877_b0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/molecules23010153","article-title":"Novel 6- and 7-substituted coumarins with inhibitory action against lipoxygenase and tumor-associated carbonic anhydrase IX","volume":"23","author":"Peperidou","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2021.127877_b0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1476-5381.1972.tb07252.x","article-title":"Some pharmacological properties of piperazine","volume":"44","author":"Mason","year":"1972","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmcl.2021.127877_b0060","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1016\/j.bmcl.2010.05.020","article-title":"Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activity","volume":"20","author":"Chetan","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2021.127877_b0065","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/13543776.2016.1189902","article-title":"Piperazine derivatives for therapeutic use: a patent review (2010-present)","volume":"26","author":"Rathi","year":"2016","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmcl.2021.127877_b0070","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1111\/cbdd.13578","article-title":"Synthesis and biological evaluation of morpholines linked coumarin\u2013triazole hybrids as anticancer agents","volume":"94","author":"Goud","year":"2019","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmcl.2021.127877_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103663","article-title":"Synthesis, 18F-radiolabeling and apoptosis inducing studies of novel 4, 7-disubstituted coumarins","volume":"97","author":"Goud","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2021.127877_b0080","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/jhet.3819","article-title":"Synthesis, molecular docking simulation, and biological evaluation studies of novel amide and ether conjugates of 2,3-diaryl-1,3-thiazolidin-4-ones","volume":"57","author":"Daipule","year":"2020","journal-title":"J Heterocycl Chem"},{"key":"10.1016\/j.bmcl.2021.127877_b0085","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2021.127877_b0090","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1021\/jm050483n","article-title":"Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors","volume":"48","author":"Nishimori","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.127877_b0095","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/14756366.2014.942659","article-title":"New series of sulfonamides containing amino acid moiety act as effective and selective inhibitors of tumor-associated carbonic anhydrase XII","volume":"30","author":"Ceruso","year":"2015","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmcl.2021.127877_b0100","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3109\/14756366.2014.948435","article-title":"Exploring QSARs of some benzenesulfonamides incorporating cyanoacrylamide moieties as a carbonic anhydrase inhibitor (specifically against tumor-associated isoforms IX and XII)","volume":"30","author":"Alafeefy","year":"2015","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmcl.2021.127877_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103016","article-title":"Synthesis of 1-benzyl-1H-benzimidazoles as galectin-1 mediated anticancer agents","volume":"89","author":"Goud","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2021.127877_b0110","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/cbdd.13363","article-title":"An efficient and facile green synthesis of bisindole methanes as potential Mtb FtsZ inhibitors","volume":"92","author":"Khadkikar","year":"2018","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmcl.2021.127877_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105684","article-title":"Novel trisaccharide based phospholipids as immunomodulators","volume":"74","author":"Bonam","year":"2019","journal-title":"Int Immunopharmacol"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21001037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21001037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:38:30Z","timestamp":1760773110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21001037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":23,"alternative-id":["S0960894X21001037"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.127877","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of novel 4,7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.127877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"127877"}}